AstraZeneca Crestor Should Be Withdrawn For Safety Reasons, Public Citizen Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Petition cites 22 cases of "serious" post-marketing events, including rhabdomyolysis, kidney problems and bleeding, in the U.S., U.K. and Canada.